India  
 
NewsR.in

United States: A Winning Streak? IRA's Drug Price Negotiation Program Survives Again - Crowell & Moring LLP

Mondaq Wednesday, 6 March 2024
On March 1, 2024, Judge Colm F. Connolly of the District of Delaware granted the government's motion for summary judgment in the first substantive ruling on the constitutionality of the Inflation Reduction Act ("IRA").
0
shares		ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

United States: Mintz IRA Update — Legal Challenges To The Medicare Drug Price Negotiation Program Continue - Mintz

 The IRA's Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program"), which aims to lower drug prices by enabling the federal government to...
Mondaq

United States: Mintz IRA Update — Demystifying The IRA's Small Biotech Exception - Mintz

 On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price...
Mondaq

United States: Mintz IRA Update — The IRA In 2024: The Medicare Drug Price Negotiation Program In Full Swing And Other Developments - Mintz

 Our team's preparation for the year includes a review of the anticipated impact of the IRA on the health care industry in 2024.
Mondaq